Bystander-mediated stimulation of proteolipid protein-specific regulatory T (Treg) cells confers protection against experimental autoimmune encephalomyelitis (EAE) via TGF-β

Journal of Neuroimmunology

Volumn 245, Issue 1-2, 2012, Pages 39-47

  Jun, Sang Mu ^a   Ochoa Repáraz, Javier ^b   Zlotkowska, Dagmara ^c   Hoyt, Teri ^a   Pascual, David W ^a  

^a MONTANA STATE UNIVERSITY   (United States)

^b TA Neurodegenerative Diseases Inc   (United States)

^c Institute of Food Research   (United States)

Author keywords

Experimental autoimmune encephalomyelitis; Salmonella; TGF

Indexed keywords

BACTERIAL ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; PROTEOLIPID PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL COLONIZATION; BYSTANDER EFFECT; CD4+ CD25+ T LYMPHOCYTE; CELL ISOLATION; CELL SPECIFICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ESCHERICHIA COLI; FEMALE; FIMBRIA; IN VIVO STUDY; LYMPHOCYTE TRANSFER; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; REGULATORY T LYMPHOCYTE; SALMONELLA; T LYMPHOCYTE ACTIVATION;

EID: 84859631922     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.02.003     Document Type: Article

References (71)

1. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the reduction of interleukin-17. J. Biol. Chem. 2003, 278:1910-1914.
2. +human thymocytes. J. Exp. Med. 2002, 196:379-387.
3. Baxter A.G. The origin and application of experimental autoimmune encephalomyelitis. Nat. Rev. Immunol. 2007, 7:904-912.
4. Becher B., Durell B.G., Noelle R.J. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J. Clin. Invest. 2002, 110:493-497.
5. Billiau A., Heremans H., Vandekerckhove F., Dijkmans R., Sobis H., Meulepas E., Carton H. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J. Immunol. 1988, 140:1506-1510.
6. +regulatory T cells. Nat. Rev. Immunol. 2011, 11:119-130.
7. +regulatory T cells by TGF-β induction of transcription factor FoxP3. J. Exp. Med. 2003, 198:1875-1886.
8. Codarri L., Gyülvészi G., Tosevski V., Hesske L., Fontana A., Magnenat L., Suter T., Becher B. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 2011, 12:560-567.
9. Collison L.W., Chaturvedi V., Henderson A.L., Giacomin P.R., Guy C., Bankoti J., Finkelstein D., Forbes K., Workman C.J., Brown S.A., Rehg J.E., Jones M.L., Ni H.T., Artis D., Turk M.J., Vignali D.A. IL-35-mediated induction of a potent regulatory T cell population. Nat. Immunol. 2010, 11:1093-1101.
10. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., Zurawski S., Wiekowski M., Lira S.A., Gorman D., Kastelein R.A., Sedqwick J.D. Interleukin-23 rather than interleukin-12 is the crucial cytokine for autoimmune inflammation of the brain. Nature 2003, 421:744-748.
11. Duong T.T., Finkelman F.D., Singh B., Strejan G.H. Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J. Neuroimmunol. 1994, 53:101-107.
12. H17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 2011, 12:568-575.
13. Falcone M., Bloom B.R. A T helper cell 2 (Th2) immune responses against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J. Exp. Med. 1997, 185:901-907.
14. Falcone M., Rajan A.J., Bloom B.R., Brosnan C.F. A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice. J. Immunol. 1998, 160:4822-4830.
15. Faria A.M., Weiner H.L. Oral tolerance. Immunol. Rev. 2005, 206:232-259.
16. Faria A.M., Maron R., Ficker S.M., Slavin A.J., Spahn T., Weiner H.L. Oral tolerance induced by continuous feeding: enhanced up-regulation of transforming growth factor-β/interleukin-10 and suppression of experimental autoimmune encephalomyelitis. J. Autoimmun. 2003, 20:135-145.
17. Ferber I.A., Brocke S., Taylor-Edwards C., Ridgway W., Dinisco C., Steinman L., Dalton D., Fathman C.G. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 1996, 156:5-7.
18. Fife B.T., Huffnagle G.B., Kuziel W.A., Karpus W.J. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 2000, 192:899-905.
19. Fiori P., Ristori G., Cacciani A., Buttinelli C., Falcone M., di Giovanni S., Montesperelli C., Pozzilli C., Salvetti M. Down-regulation of cell-surface CD4 co-receptor expression and modulation of experimental allergic encephalomyelitis. Int. Immunol. 1997, 9:541-545.
20. +regulatory T cells. Eur. J. Immunol. 2011, 41:1242-1248.
21. Getts D.R., Shankar S., Chastain E.M., Martin A., Getts M.T., Wood K., Miller S.D. Current landscape for T-cell targeting in autoimmunity and transplantation. J. Immunother. 2011, 3:853-870.
22. Gorelik L., Constant S., Flavell R.A. Mechanism of transforming growth factor β-induced inhibition of T helper type 1 differentiation. J. Exp. Med. 2002, 195:1499-1505.
23. Gran B., Zhang G.X., Yu S., Li J., Chen X.H., Ventura E.S., Kamoun M., Rostami A. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 2002, 169:7104-7110.
24. Gyülvészi G., Haak S., Becher B. IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivo. Eur. J. Immunol. 2009, 39:1864-1869.
25. Hofstetter H.H., Ibrahim S.M., Koczan D., Kruse N., Weishaupt A., Toyka K.V., Gold R. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell. Immunol. 2005, 237:123-130.
26. Inobe J., Slavin A.J., Komagata Y., Chen Y., Liu L., Weiner H.L. IL-4 is a differentiation factor for transforming growth factor-β secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur. J. Immunol. 1998, 28:2780-2790.
27. Juedes A.E., Hjelmstrom P., Bergman C.M., Neild A.L., Ruddle N.H. Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J. Immunol. 2000, 164:419-426.
28. Jun S., Gilmore W., Callis G., Rynda A., Haddad A., Pascual D.W. A live diarrheal vaccine imprints a Th2 cell bias and acts as an anti-inflammatory vaccine. J. Immunol. 2005, 175:6733-6740.
29. Karpus W.J., Kennedy K.J., Kunkel S.L., Lukacs N.W. Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines. J. Exp. Med. 1998, 187:733-741.
30. Kimura A., Naka T., Kishimoto T. IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:12099-12104.
31. Kochetkova I., Trunkle T., Callis G., Pascual D.W. Vaccination without auto-antigen protects against collagen II-induced arthritis via immune deviation and regulatory T cells. J. Immunol. 2008, 181:2741-2752.
32. +regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. J. Immunol. 2010, 184:7144-7153.
33. +cells are interdependent for protection against collagen-induced arthritis. J. Immunol. 2011, 187:4654-4666.
34. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177:566-573.
35. Kroenke M.A., Carlson T.J., Andjelkovic A.V., Segal B.M. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 2008, 205:1535-1541.
36. Lafaille J.J., Keere F., Hsu A.L., Baron J.L., Haas W., Raine C.S., Tonegawa S. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 1997, 186:307-312.
37. Langrish C.L., McKenzie B.S., Wilson N.J., de Waal Malefyt R., Kastelein R.A., Cua D.J. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 2004, 202:96-105.
38. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005, 201:233-240.
39. Li H., Nourbakhsh B., Safavi F., Li K., Xu H., Cullimore M., Zhou F., Zhang G., Rostami A. Kit (W-sh) mice develop earlier and more severe experimental autoimmune encephalomyelitis due to absence of immune suppression. J. Immunol. 2011, 187:274-282.
40. Linington C., Berger T., Perry L., Weerth S., Hinze-Selch D., Zhang Y., Lu H.C., Lassmann H., Wekerle H. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 1993, 23:1364-1372.
41. +regulatory T cells. Nat. Immunol. 2008, 9:632-640.
42. reg. Eur. J. Immunol. 2010, 40:142-152.
43. Maloy K.J., Powrie F. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2001, 2:816-822.
44. Marshall E. Drug trials. Violent reaction to monoclonal antibody therapy remains a mystery. Science 2006, 311:1688-1689.
45. +regulatory cells within the central nervous system. J. Immunol. 2005, 175:3025-3032.
46. Miller S.D., Vanderlugt C.L., Lenschow D.J., Pope J.G., Karandikar N.J., Del Canto M.C., Bluestone J.A. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 1995, 3:739-745.
47. Ochoa-Repáraz J., Riccardi C., Rynda A., Jun S., Callis G., Pascual D.W. Regulatory T cell vaccination without autoantigen protects against experimental autoimmune encephalomyelitis. J. Immunol. 2007, 178:1791-1799.
48. Ochoa-Repáraz J., Rynda A., Ascón M.A., Yang X., Kochetkova I., Riccardi C., Callis G., Trunkle T., Pascual D.W. IL-13 production by regulatory T cells protects against experimental autoimmune encephalomyelitis independently of autoantigen. J. Immunol. 2008, 181:954-968.
49. Offner H., Subramanian S., Wang C., Afentoulis M., Vandenbark A.A., Huan J., Burrows G.G. Treatment of passive experimental autoimmune encephalomyelitis in SJL mice with a recombinant TCR ligand induces IL-13 and prevents axonal injury. J. Immunol. 2005, 175:4103-4111.
50. H17 development by cooperating with ROR nuclear receptors. Nature 2010, 464:1381-1385.
51. Olsson T. Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis. Neurology 1995, 45:S11-S15.
52. Pascual D.W., Hone D.M., Hall S., van Ginkel F.W., Yamamoto M., Walters N., Fujihashi K., Powell R.J., Wu S., Vancott J.L., Kiyono H., McGhee J.R. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response. Infect. Immun. 1999, 67:6249-6256.
53. Pascual D.W., Trunkle T., Sura J. Fimbriated Salmonella enterica serovar Typhimurium abates initial inflammatory responses by macrophages. Infect. Immun. 2002, 70:4273-4281.
54. +regulatory T cells. Cell Death Differ. 2007, 14:2076-2084.
55. Rynda A., Maddaloni M., Mierzejewska D., Ochoa-Repáraz J., Maślanka T., Crist K., Riccardi C., Barszczewska B., Fujihashi K., McGhee J.R., Pascual D.W. Low-dose tolerance is mediated by microfold cell ligand, reovirus protein σ1. J. Immunol. 2008, 180:5187-5200.
56. regcells in protein σ1-mediated protection against murine experimental autoimmune encephalomyelitis (EAE). PLoS One 2010, 5:e8720.
57. Rynda-Apple A., Huarte E., Maddaloni M., Callis G., Skyberg J.A., Pascual D.W. Active immunization using a single dose immunotherapeutic abates established EAE via IL-10 and regulatory T cells. Eur. J. Immunol. 2011, 41:313-323.
58. +regulatory T cells in the human immune system. Nat. Rev. Immunol. 2010, 10:490-500.
59. +precursors. J. Immunol. 2005, 175:6107-6116.
60. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005, 23:683-747.
61. reg. Eur. J. Immunol. 2009, 39:1108-1117.
62. Sutton C., Brereton C., Keogh B., Mills K.H., Lavelle E.C. A crucial role for interleukin 1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 2006, 203:1685-1691.
63. +immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002, 99:3493-3499.
64. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
65. +regulatory T cells. J. Immunol. 2004, 172:5986-5993.
66. Walters N., Sura M., Trunkle T., Pascual D.W. Enhanced immunoglobulin A response and protection against Salmonella enterica serovar Typhimurium in the absence of the substance P receptor. Infect. Immun. 2005, 73:317-324.
67. Willenborg D.O., Fordham S., Bernard C.C., Cowden W.B., Ramshaw I.A. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 1996, 157:3323-3327.
68. Williams J.L., Kithcart A.P., Smith K.M., Shawler T., Cox G.M., Whitacre C.C. Memory cells specific for myelin oligodendrocyte glycoprotein (MOG) govern the transfer of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2011, 234:84-92.
69. Young D.A., Lowe L.D., Booth S.S., Whitters M.J., Nicholson L., Kuchroo V.K., Collins M. IL-4, IL-10, IL-13, and TGF-β from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis. J. Immunol. 2000, 164:3563-3572.
70. Yu P., Gregg R.K., Bell J.J., Ellis J.S., Divekar R., Lee H.H., Jain R., Waldner H., Hardaway J.C., Collins M., Kuchroo V.K., Zaghouani H. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen. J. Immunol. 2005, 174:6772-6780.
71. +regulatory T cells induced by IL-2 and TGF-β are resistant to Th17 conversion by IL-6. J. Immunol. 2008, 180:7112-7116.